CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 224 enrolled
Drug / intervention
liposomal bupivacaine plus free bupivacaine +3 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05280197
NCT05280197N/ACompleted
CompareCT.gov

Benefit of Intraoperative TAP Blocks for Kidney Transplantation- a Randomized, Placebo Controlled Trial

The Cleveland Clinic·interventional·Posted Mar 15, 2022·Updated Jun 18, 2025

In Brief

A clinical study evaluating TAP block, liposomal bupivacaine plus free bupivacaine, and 1 other intervention for Kidney Transplantation. Completed, enrolled 224 participants across 1 site.

Detailed Summary

This is a randomized, placebo controlled, double blind study to determine the effectiveness of a Transversus Abdominis Plane (TAP) block for reducing postoperative pain and opioid use in kidney transplant recipients.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsKidney Transplantation
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20222023202420252026
First PostedMar 15, 2022
Enrollment StartJan 8, 2022
Primary CompletionMar 24, 2023
Study CompletionNov 8, 2023
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 4.3 years ago

Interventions

TAP blockprocedure

Transversus abdominis plane (TAP) nerve block with liposomal bupivacaine plus free bupivacaine

TAP blockprocedure

Transversus abdominis plane (TAP) nerve block with normal saline

liposomal bupivacaine plus free bupivacainedrug

TAP block using liposomal bupivacaine plus free bupivacaine

normal salinedrug

TAP block using normal saline